Community mass treatment with azithromycin for trachoma: Factors associated with change in participation of children from the first to the second round.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Clinical Epidemiology and Global Health

• Publication date

  2015-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.CEGH.2013.06.001PMID 26462290PMCID PMC4599782
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Disease of Poverty.

  2016cited by this paper
• Azithromycin Mass Treatment for Trachoma Control: Risk Factors for Non-Participation of Children in Two Treatment Rounds

  2012cited by this paper
• Number of Years of Annual Mass Treatment With Azithromycin Needed to Control Trachoma in Hyper-endemic Communities in Tanzania

  2011cited by this paper
• Design and Baseline Data of a Randomized Trial to Evaluate Coverage and Frequency of Mass Treatment with Azithromycin: The Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia

  2011cited by this paper
• Mass Treatment with Azithromycin for Trachoma Control: Participation Clusters in Households

  2010cited by this paper
• Estimating Household and Community Transmission of Ocular Chlamydia trachomatis

  2009cited by this paper
• Is mass treatment the appropriate schistosomiasis elimination strategy?

  2008cited by this paper
• Eliminating blinding trachoma.

  2008cited by this paper
• Trachoma: global magnitude of a preventable cause of blindness

  2008cited by this paper
• An Eye for Inequality: How Trachoma Relates to Poverty in Tanzania and Vietnam

  2007cited by this paper
• Spatial clustering of ocular chlamydial infection over time following treatment, among households in a village in Tanzania.

  2006cited by this paper
• Refusal to take ivermectin: the associated 'risk' factors in Hoima district, Uganda

  2005cited by this paper
• Acceptability of azithromycin for the control of trachoma in Northern Tanzania.

  2005cited by this paper
• Blinding Trachoma: A Disease of Poverty

  2004cited by this paper
• Factors associated with coverage in community‐directed treatment with ivermectin for onchocerciasis control in Oyo State, Nigeria

  2002cited by this paper
• Ivermectin-based control of onchocerciasis in northern Cameroon: individual factors influencing participation in community treatment.

  1996cited by this paper
• Maintaining compliance to ivermectin in communities in two West African countries.

  1996cited by this paper
• Social Networks and Social Care in Tanzania

  1993cited by this paper
• Epidemiology of ocular chlamydial infection in a trachoma-hyperendemic area.

  1991cited by this paper
• A behavioral model of families' use of health services

  1968cited by this paper

• Azithromycin distribution and childhood mortality in compliance-related subgroups in Niger: complier average causal effect and spillovers in a cluster-randomized, placebo-controlled trial.

  2021cites this paper
• Population coverage and factors associated with participation following a mass drug administration of azithromycin for trachoma elimination in Amhara, Ethiopia

  2019cites this paper
• Ocular Chlamydia trachomatis infection: elimination with mass drug administration

  2019cites this paper
• Non-Participation during Azithromycin Mass Treatment for Trachoma in The Gambia: Heterogeneity and Risk Factors

  2014cites this paper